Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.

Neth BJ, Mintz A, Whitlow C, Jung Y, Solingapuram Sai K, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J, Heslegrave AJ, Blennow K, Cunnane SC, Castellano CA, Zetterberg H, Craft S.

Neurobiol Aging. 2019 Sep 26. pii: S0197-4580(19)30336-7. doi: 10.1016/j.neurobiolaging.2019.09.015. [Epub ahead of print]

PMID:
31757576
2.

Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence.

Craft S, Winstock A, Ferris J, Mackie C, Lynskey MT, Freeman TP.

Psychol Med. 2019 Oct 13:1-10. doi: 10.1017/S0033291719002460. [Epub ahead of print]

PMID:
31607281
3.

Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.

Nagpal R, Neth BJ, Wang S, Craft S, Yadav H.

EBioMedicine. 2019 Sep;47:529-542. doi: 10.1016/j.ebiom.2019.08.032. Epub 2019 Aug 30.

4.

Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.

Mustapic M, Tran J, Craft S, Kapogiannis D.

J Alzheimers Dis. 2019;69(2):489-498. doi: 10.3233/JAD-180578.

PMID:
30958348
5.

Using Varying Diagnostic Criteria to Examine Mild Cognitive Impairment Prevalence and Predict Dementia Incidence in a Community-Based Sample.

Robertson K, Larson EB, Crane PK, Cholerton B, Craft S, McCormick WC, McCurry SM, Bowen JD, Baker LD, Trittschuh EH.

J Alzheimers Dis. 2019;68(4):1439-1451. doi: 10.3233/JAD-180746.

PMID:
30909213
6.

ELF4 facilitates innate host defenses against Plasmodium by activating transcription of Pf4 and Ppbp.

Wang D, Zhang Z, Cui S, Zhao Y, Craft S, Fikrig E, You F.

J Biol Chem. 2019 May 10;294(19):7787-7796. doi: 10.1074/jbc.RA118.006321. Epub 2019 Mar 21.

PMID:
30898878
7.

Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces.

Nagpal R, Wang S, Solberg Woods LC, Seshie O, Chung ST, Shively CA, Register TC, Craft S, McClain DA, Yadav H.

Front Microbiol. 2018 Nov 30;9:2897. doi: 10.3389/fmicb.2018.02897. eCollection 2018.

8.

A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis.

Latimer CS, Shively CA, Keene CD, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson AM, Neth BJ, Mintz A, Maldjian JA, Whitlow CT, Kaplan JR, Craft S.

Alzheimers Dement. 2019 Jan;15(1):93-105. doi: 10.1016/j.jalz.2018.06.3057. Epub 2018 Nov 19.

9.

A mosquito salivary gland protein partially inhibits Plasmodium sporozoite cell traversal and transmission.

Schleicher TR, Yang J, Freudzon M, Rembisz A, Craft S, Hamilton M, Graham M, Mlambo G, Tripathi AK, Li Y, Cresswell P, Sinnis P, Dimopoulos G, Fikrig E.

Nat Commun. 2018 Jul 25;9(1):2908. doi: 10.1038/s41467-018-05374-3.

10.

Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice.

Dragovic SM, Agunbiade TA, Freudzon M, Yang J, Hastings AK, Schleicher TR, Zhou X, Craft S, Chuang YM, Gonzalez F, Li Y, Hrebikova G, Tripathi A, Mlambo G, Almeras L, Ploss A, Dimopoulos G, Fikrig E.

Cell Host Microbe. 2018 Apr 11;23(4):523-535.e5. doi: 10.1016/j.chom.2018.03.008.

11.

Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study.

Hughes TM, Wagenknecht LE, Craft S, Mintz A, Heiss G, Palta P, Wong D, Zhou Y, Knopman D, Mosley TH, Gottesman RF.

Neurology. 2018 Apr 3;90(14):e1248-e1256. doi: 10.1212/WNL.0000000000005259. Epub 2018 Mar 16.

12.

Care Management to Promote Treatment Adherence in Patients with Cognitive Impairment and Vascular Risk Factors: A Demonstration Project.

Bonner LM, Hanson A, Robinson G, Lowy E, Craft S.

J Prev Alzheimers Dis. 2018;5(1):36-41. doi: 10.14283/jpad.2017.28.

PMID:
29405231
13.

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM.

Nat Rev Neurol. 2018 Mar;14(3):168-181. doi: 10.1038/nrneurol.2017.185. Epub 2018 Jan 29. Review.

14.

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.

Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH; ADMET 2 Research Group.

Trials. 2018 Jan 18;19(1):46. doi: 10.1186/s13063-017-2406-5.

15.

Antemortem Diagnosis of Coxiellosis in a Blue and Gold Macaw ( Ara ararauna).

Flanders AJ, Rosenberg JF, Bercier M, Leissinger MK, Black LJ, Giglio RF, Craft SLM, Zoll WM, Childress AL, Wellehan JFX.

J Avian Med Surg. 2017 Dec;31(4):364-372. doi: 10.1647/2016-224.

PMID:
29327963
16.

Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages.

Neth BJ, Craft S.

Front Aging Neurosci. 2017 Oct 31;9:345. doi: 10.3389/fnagi.2017.00345. eCollection 2017. Review.

17.

Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Barrett EJ, Liu Z, Khamaisi M, King GL, Klein R, Klein BEK, Hughes TM, Craft S, Freedman BI, Bowden DW, Vinik AI, Casellini CM.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4343-4410. doi: 10.1210/jc.2017-01922. Review.

18.

A 6-bp Deletion Variant in a Novel Canine Glutathione-S-Transferase Gene (GSTT5) Leads to Loss of Enzyme Function.

Craft S, Ekena J, Sacco J, Luethcke K, Trepanier L.

J Vet Intern Med. 2017 Nov;31(6):1833-1840. doi: 10.1111/jvim.14861. Epub 2017 Nov 3.

19.

Blood-Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism.

Tyrrell DJ, Bharadwaj MS, Jorgensen MJ, Register TC, Shively C, Andrews RN, Neth B, Keene CD, Mintz A, Craft S, Molina AJA.

Oxid Med Cell Longev. 2017;2017:7317251. doi: 10.1155/2017/7317251. Epub 2017 Oct 2.

20.

First Metatarsophalangeal Joint Fusion With Use of Crossed Kirschner Wires and Intramedullary Steinmann Pin.

Karlock LG, Berry L, Craft ST, Petrozzi R, Grahn AG, Casteel ML.

J Foot Ankle Surg. 2017 Nov - Dec;56(6):1139-1142. doi: 10.1053/j.jfas.2017.05.012.

PMID:
29079230
21.

Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance.

Banks WA, Farr SA, Salameh TS, Niehoff ML, Rhea EM, Morley JE, Hanson AJ, Hansen KM, Craft S.

Int J Obes (Lond). 2018 Mar;42(3):391-397. doi: 10.1038/ijo.2017.231. Epub 2017 Oct 9.

22.

Characterization of a low expression haplotype in canine glutathione S-transferase (GSTT1) and its prevalence in golden retrievers.

Craft S, Ekena J, Mayer B, Thamm DH, Saba C, Chun R, Trepanier LA.

Vet Comp Oncol. 2018 Mar;16(1):E61-E67. doi: 10.1111/vco.12333. Epub 2017 Aug 25.

PMID:
28840668
23.

Automated synthesis of 1-[11C]acetoacetate on a TRASIS AIO module.

Solingapuram Sai KK, Donald Gage H, Almaguel F, Neth B, Hughes TM, Tremblay S, Castellano CA, Cunnane SC, Jorgensen MJ, Craft S, Mintz A.

Appl Radiat Isot. 2017 Nov;129:57-61. doi: 10.1016/j.apradiso.2017.07.066. Epub 2017 Aug 2.

24.

Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis.

Hughes TM, Craft S, Baker LD, Espeland MA, Rapp SR, Sink KM, Bertoni AG, Burke GL, Gottesman RF, Michos ED, Luchsinger JA, Fitzpatrick AL, Hayden KM.

Alzheimers Dement (Amst). 2017 Mar 31;8:18-25. doi: 10.1016/j.dadm.2017.03.003. eCollection 2017.

25.

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.

Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S.

J Alzheimers Dis. 2017;57(4):1325-1334. doi: 10.3233/JAD-161256.

26.

Radiolabeling and initial biological evaluation of [18F]KBM-1 for imaging RAR-α receptors in neuroblastoma.

Solingapuram Sai KK, Das BC, Sattiraju A, Almaguel FG, Craft S, Mintz A.

Bioorg Med Chem Lett. 2017 Mar 15;27(6):1425-1427. doi: 10.1016/j.bmcl.2017.01.093. Epub 2017 Feb 1.

27.

Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4.

Postupna N, Latimer CS, Larson EB, Sherfield E, Paladin J, Shively CA, Jorgensen MJ, Andrews RN, Kaplan JR, Crane PK, Montine KS, Craft S, Keene CD, Montine TJ.

Am J Pathol. 2017 Apr;187(4):884-895. doi: 10.1016/j.ajpath.2016.12.010. Epub 2017 Feb 16.

28.

National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.

Gifford AR, Lawrence JA, Baker LD, Balcueva EP, Case D, Craft S, Curtis AE, Griffin L, Groteluschen DL, Klepin HD, Lesser GJ, Messino MJ, Naughton M, Samuel TA, Rapp S, Sachs B, Sink KM, Williamson J, Shaw EG.

J Oncol Research. 2017;1(1). pii: 101. Epub 2017 Oct 20.

29.

Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation.

Snyder HM, Ahles T, Calderwood S, Carrillo MC, Chen H, Chang CH, Craft S, De Jager P, Driver JA, Fillit H, Knopman D, Lotze M, Tierney MC, Petanceska S, Saykin A, Seshadri S, Shineman D, Ganguli M.

Alzheimers Dement. 2017 Mar;13(3):267-273. doi: 10.1016/j.jalz.2016.11.002. Epub 2016 Dec 18. Review.

30.

Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome.

Voigt A, Esfandiary L, Wanchoo A, Glenton P, Donate A, Craft WF, Craft SL, Nguyen CQ.

Sci Rep. 2016 Dec 13;6:38717. doi: 10.1038/srep38717.

31.

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.

Cholerton B, Baker LD, Montine TJ, Craft S.

Diabetes Spectr. 2016 Nov;29(4):210-219.

32.

Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.

Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J, Rapp PR, Yaffe K, Carrillo MC.

Alzheimers Dement. 2016 Nov;12(11):1186-1196. doi: 10.1016/j.jalz.2016.08.004. Epub 2016 Sep 27. Review.

PMID:
27692800
33.

What is your diagnosis? Perineal mass in a dog.

Weeden AL, Struthers JD, Craft SL, Souza CH, Stacy NI.

Vet Clin Pathol. 2016 Jun;45(2):385-6. doi: 10.1111/vcp.12341. Epub 2016 Apr 19. No abstract available.

PMID:
27093459
34.

Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study.

Hanson AJ, Banks WA, Hernandez Saucedo H, Craft S.

Dement Geriatr Cogn Dis Extra. 2016 Mar 16;6(1):78-89. doi: 10.1159/000444079. eCollection 2016 Jan-Apr.

35.

Epilepsy with myoclonic-atonic seizures (Doose syndrome): When video-EEG polygraphy holds the key to syndrome diagnosis.

Dragoumi P, Chivers F, Brady M, Craft S, Mushati D, Venkatachalam G, Cross JH, Das KB.

Epilepsy Behav Case Rep. 2015 Oct 28;5:31-3. doi: 10.1016/j.ebcr.2015.10.001. eCollection 2016.

36.

Associations between Markers of Glucose and Insulin Function and Cognitive Function in Healthy African American Elders.

Skinner JS, Morgan A, Hernandez-Saucedo H, Hansen A, Corbett S, Arbuckle M, Leverenz JB, Wilkins CH, Craft S, Baker LD.

J Gerontol Geriatr Res. 2015 Aug;4(4). pii: 232. Epub 2015 Jul 23.

37.

The role of insulin in the vascular contributions to age-related dementia.

Hughes TM, Craft S.

Biochim Biophys Acta. 2016 May;1862(5):983-91. doi: 10.1016/j.bbadis.2015.11.013. Epub 2015 Dec 2. Review.

38.

Montreal Cognitive Assessment and Modified Mini Mental State Examination in African Americans.

Sink KM, Craft S, Smith SC, Maldjian JA, Bowden DW, Xu J, Freedman BI, Divers J.

J Aging Res. 2015;2015:872018. doi: 10.1155/2015/872018. Epub 2015 Nov 4.

39.

Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.

Espeland MA, Brinton RD, Hugenschmidt C, Manson JE, Craft S, Yaffe K, Weitlauf J, Vaughan L, Johnson KC, Padula CB, Jackson RD, Resnick SM; WHIMS Study Group.

Diabetes Care. 2015 Dec;38(12):2316-24. doi: 10.2337/dc15-1385. Epub 2015 Oct 20.

40.

Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker.

Oh ES, Marano CM, Leoutsakos JM, Lee RW, Rissman RA, Smith GS, Craft S, Lyketsos CG.

Alzheimers Dement (Amst). 2015 Sep;1(3):311-315.

41.

Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.

Hanson AJ, Bayer JL, Baker LD, Cholerton B, VanFossen B, Trittschuh E, Rissman RA, Donohue MC, Moghadam SH, Plymate SR, Craft S.

J Alzheimers Dis. 2015;48(1):205-18. doi: 10.3233/JAD-150273.

PMID:
26401941
42.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.

Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2015 Oct 20;85(16):1383-91. doi: 10.1212/WNL.0000000000002035. Epub 2015 Sep 11.

43.

Bilateral microphthalmos with cyst in a neonatal foal.

Greenberg SM, Plummer CE, Sledge D, Komine M, Craft SL, Conway JA.

Vet Ophthalmol. 2016 Jul;19(4):332-339. doi: 10.1111/vop.12299. Epub 2015 Jul 27.

PMID:
26215738
44.

Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes.

Espeland MA, Brinton RD, Manson JE, Yaffe K, Hugenschmidt C, Vaughan L, Craft S, Edwards BJ, Casanova R, Masaki K, Resnick SM; WHIMS-MRI2 Study Group.

Neurology. 2015 Sep 29;85(13):1131-8. doi: 10.1212/WNL.0000000000001816. Epub 2015 Jul 10.

45.

Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'.

Hughes TM, Craft S, Lopez OL.

Neurodegener Dis Manag. 2015;5(2):121-35. doi: 10.2217/nmt.14.53. Review.

46.

Long Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia.

Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.

J Alzheimers Dis. 2015;45(4):1269-70. doi: 10.3233/JAD-159002. No abstract available.

PMID:
25869922
47.

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease.

Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC.

Alzheimers Dement. 2015 Jun;11(6):710-7. doi: 10.1016/j.jalz.2014.10.008. Epub 2014 Dec 12. Review.

48.

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.

Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.

J Alzheimers Dis. 2015;44(3):897-906. doi: 10.3233/JAD-141791. Erratum in: J Alzheimers Dis. 2015;45(4):1269-70.

PMID:
25374101
49.

Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes.

Weinstein JS, Lezon-Geyda K, Maksimova Y, Craft S, Zhang Y, Su M, Schulz VP, Craft J, Gallagher PG.

Blood. 2014 Dec 11;124(25):3719-29. doi: 10.1182/blood-2014-06-582700. Epub 2014 Oct 20.

50.

The APOE genotype: modification of therapeutic responses in Alzheimer's disease.

Hanson AJ, Craft S, Banks WA.

Curr Pharm Des. 2015;21(1):114-20. Review.

PMID:
25330331

Supplemental Content

Support Center